Conversion to Monotherapy Study With Keppra XR for Partial Seizures

Completed · Phase 3 · Has a placebo group

Conditions studied: Epilepsy

In brief

The primary objective of this study is to assess the efficacy of two doses of Keppra XR compared with a historical control as the placebo, in the monotherapy treatment of partial onset seizures.

Key facts

Study ID

NCT00419094

Run by

UCB Pharma

People needed

228

Starts

2007-08-01

Expected to finish

2009-09-01

Last updated by the study team

2014-09-05

Who can join

Age: 12 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male or female subjects 12 to 75 years of age.
• Subjects must have inadequately controlled partial onset epilepsy.
• Subjects must be experiencing 2 to 40 seizures per 4-week period while being maintained on one or two standard AED(s)

You may not qualify if…

• A history of status epilepticus in the 6 months preceding randomization.
• Significant medical, psychiatric or neurological illness.
• Intake of benzodiazepines on more than an occasional basis
• History of previous treatment with levetiracetam or sensitivity to levetiracetam.

Where it is running

• Study site — Dothan, Alabama, United States
• Study site — Northport, Alabama, United States
• Study site — Phoenix, Arizona, United States
• Study site — Little Rock, Arkansas, United States
• Study site — Bakersfield, California, United States
• Study site — Jacksonville, Florida, United States
• Study site — Loxahatchee Groves, Florida, United States
• Study site — Atlanta, Georgia, United States
• Study site — Suwanee, Georgia, United States
• Study site — Winfield, Illinois, United States
• Study site — Witchita, Kansas, United States
• Study site — Shreveport, Louisiana, United States
• Study site — Bethesda, Maryland, United States
• Study site — Detroit, Michigan, United States
• Study site — Camden, New Jersey, United States
• Study site — New Brunswick, New Jersey, United States
• Study site — Buffalo, New York, United States
• Study site — Cedarhurst, New York, United States
• Study site — Toledo, Ohio, United States
• Study site — Tulsa, Oklahoma, United States
• Study site — Bend, Oregon, United States
• Study site — Monaca, Pennsylvania, United States
• Study site — Philadelphia, Pennsylvania, United States
• Study site — Beaufort, South Carolina, United States
• Study site — Monterrey, Nuevo León, Mexico

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.